364 related articles for article (PubMed ID: 32649060)
1. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
Rivera T; Zhao Y; Ni Y; Wang J
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
[TBL] [Abstract][Full Text] [Related]
2. cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA.
Ni Y; Zhao Y; Warren L; Higginbotham J; Wang J
Curr Protoc Stem Cell Biol; 2016 Nov; 39(1):4A.6.1-4A.6.25. PubMed ID: 31816187
[TBL] [Abstract][Full Text] [Related]
3. cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.
Parr AM; Walsh PJ; Truong V; Dutton JR
Methods Mol Biol; 2016; 1357():221-9. PubMed ID: 25863788
[TBL] [Abstract][Full Text] [Related]
4. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
[TBL] [Abstract][Full Text] [Related]
5. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
8. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
9. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
10. Scalable production of transplantable dopaminergic neurons from hESCs and iPSCs in xeno-free defined conditions.
Swistowski A; Zeng X
Curr Protoc Stem Cell Biol; 2012 Aug; Chapter 2():Unit2D.12. PubMed ID: 22872425
[TBL] [Abstract][Full Text] [Related]
11. Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.
Wiley LA; Anfinson KR; Cranston CM; Kaalberg EE; Collins MM; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2017 Aug; 42():4A.12.1-4A.12.14. PubMed ID: 28806854
[TBL] [Abstract][Full Text] [Related]
12. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
13. Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.
Skorik C; Mullin NK; Shi M; Zhang Y; Hunter P; Tang Y; Hilton B; Schlaeger TM
Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e103. PubMed ID: 31977148
[TBL] [Abstract][Full Text] [Related]
14. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
Rajala K; Lindroos B; Hussein SM; Lappalainen RS; Pekkanen-Mattila M; Inzunza J; Rozell B; Miettinen S; Narkilahti S; Kerkelä E; Aalto-Setälä K; Otonkoski T; Suuronen R; Hovatta O; Skottman H
PLoS One; 2010 Apr; 5(4):e10246. PubMed ID: 20419109
[TBL] [Abstract][Full Text] [Related]
15. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
16. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
17. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
18. Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.
Shafa M; Yang F; Fellner T; Rao MS; Baghbaderani BA
Front Med (Lausanne); 2018; 5():69. PubMed ID: 29600249
[TBL] [Abstract][Full Text] [Related]
19. Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA.
Annand RR
Methods Mol Biol; 2021; 2239():163-174. PubMed ID: 33226619
[TBL] [Abstract][Full Text] [Related]
20. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
Durruthy JD; Sebastiano V
Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
